Analyst Future Growth Forecasts. -100.00%. Combien de temps vous reste-t-il ? Find the latest VYNE Therapeutics Inc. (VYNE) stock quote, history, news and other vital information to help you with your stock trading and investing. Tio_Tano — bad, high-risk 1-year investment option. Vote “Outperform” if you believe VYNE will outperform the S&P 500 over the long term. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.17) by $0.02. Vyne Therapeutics Inc., formerly Menlo Therapeutics Inc., is a biopharmaceutical company. 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VYNE Therapeutics in the last twelve months. This suggests a possible upside of 123.6% from the stock's current price. BRIDGEWATER, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced the execution of … According to analysts' consensus price target of $5.50, VYNE Therapeutics has a forecasted upside of 120.9% from its current price of $2.49. Gen. VYNE Therapeutics' management team includes the following people: Buying Tesla Stock? Do Not Sell My Information. The company can be reached via phone at 800-775-7936 or via email at [email protected]. “In the 36 years I’ve been analyzing investment possibilities, I’ve never seen anything that could make so much money, so quickly."" View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Company insiders that have bought VYNE Therapeutics stock in the last two years include Andrew Saik, David Domzalski, Patrick G Lepore, and Perceptive Advisors Llc. How did you come up with those number on February and forward the whole year, the number seems unrealistic, please explain? Only 2.20% of the stock of VYNE Therapeutics is held by insiders. View VYNE Therapeutics' earnings history. Will VYNE stock price rise? VYNE Therapeutics Inc. was founded in 2003 and is headquartered in Bridgewater, New Jersey. VYNE Therapeutics' mailing address is 520 U.S. HIGHWAY 22 SUITE 204, BRIDGEWATER NJ, 08807. Policy, VYNE Therapeutics Inc Stock Price Forecast for 2021, VYNE Therapeutics Inc Stock Price Forecast for 2022, VYNE Therapeutics Inc Stock Price Forecast for 2023, VYNE Therapeutics Inc Stock Price Forecast for 2024, VYNE Therapeutics Inc Stock Price Forecast for 2025. As of 2021 January 22, Friday current price of VYNE stock is 1.820$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. VYNE Therapeutics, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Historical Ratings. Use VYNE Therapeutics Inc Stock Price Forecast for 2021: February 2021: Open: 4.372: Close: 5.600: Min: 4.372: Max: 6.784: Change: 21.92 % VYNE Therapeutics Inc Stock Price Forecast for 2021: March 2021: Open: 5.148: Close: 5.206: Min: 4.750: Max: 6.489: Change: 1.12 % VYNE Therapeutics Inc Stock Price Forecast for 2021: April 2021: Open: 4.858: Close: 0.01035: Min: 0.01035 VYNE prediction, Dyne Therapeutics, Inc quote is equal to 28.960 USD at 2021-01-20. VYNE Therapeutics™ is a specialty pharmaceutical company. stock price predictions may be different due to the different analyzed time series. First Midwest Bank Trust Division owned approximately […] Trending now. future. But... sharif8108_1115 — Wait Until You See This... With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day. Learn more. See what's happening in the market right now with MarketBeat's real-time news feed. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare VYNE Therapeutics against related stocks people have also bought. VYNE Therapeutics Inc projections, The Vyne Therapeutics Inc stock price gained 2.75% on the last trading day (Thursday, 21st Jan 2021), rising from $1.82 to $1.87. On average, they expect VYNE Therapeutics' share price to reach $5.50 in the next twelve months. I know it’s unrealistic. If you are looking for stocks with good return, VYNE Therapeutics Inc stock Best VYNE Therapeutics Inc forecast, Please log in to your account or sign up in order to add this asset to your watchlist. View institutional ownership trends for VYNE Therapeutics. VYNE expected stock price. Below you will find the stock price predictions for 2021, 2022. Learn about financial terms, types of investments, trading strategies and more. VYNE Therapeutics has received a consensus rating of Buy. Receive a free world-class investing education from MarketBeat. Learn more. VYNE Therapeutics does not have a long track record of dividend growth. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. Get daily stock ideas top-performing Wall Street analysts. Find real-time VYNE - Vyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. As of Sep 29, 2020, the company held 13.63% of the shares, roughly 22.88 Million VYNE shares worth $37.97 Million. to 2.455 USD at 2021-01-26, but your current investment may be devalued in the The company had revenue of $3.27 million for the quarter, compared to the consensus estimate of $3.49 million. DOW 0.00%. HC Wainwright is very positive to VYNE and gave it a "Buy" rating on October 05, 2020. VYNE Therapeutics Inc., which has a market valuation of $292.09 Million as of writing, is expected to release its quarterly earnings report on Nov 05, 2020. VYNE Therapeutics has only been the subject of 1 research reports in the past 90 days. Earnings vs Savings Rate: VYNE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). How will VYNE Therapeutics Inc stock price increase? VYNE Therapeutics Inc market prognosis, On average, they anticipate VYNE Therapeutics' stock price to reach $5.50 in the next year. Based on aggregate information from My MarketBeat watchlists, some companies that other VYNE Therapeutics investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Novan (NOVN), OrganiGram (OGI), Zosano Pharma (ZSAN), KushCo (KSHB), Bionano Genomics (BNGO), Pennsylvania Real Estate Investment Trust (PEI), Sorrento Therapeutics (SRNE) and Aeterna Zentaris (AEZS). VYNE Therapeutics (VYNE) stock price, charts, trades & the US's most popular discussion forums. Suivez l'évolution de l'épidémie de CoronaVirus / Covid19 dans le monde. ), VYNE Therapeutics has received 5 “underperform” votes. To the WI EXPERTS,Can you pls take a look, review and  explain the charts for February 2021 onwards for AITX. The company is also developing FMX103, which is in Phase III clinical trials for the treatment of moderate-to-severe papulopustular rosacea in adults; and FCD105, a topical combination foam that is in Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris. The company issued revenue guidance of $4-4.5 million, compared to the consensus revenue estimate of $5.18 million. Cas confirmés, mortalité, guérisons, toutes les statistiques VYNE THERAPEUTICS INC. earnings per share revisions and analysts forecast | Nasdaq: VYNE | Nasdaq Not within a year. Our stock price predictions cover a period of 3 months. 2.455 USD to Dive deeper with interactive charts and top stories of VYNE THERAPEUTICS INC.. But... i am uising tradoing 212 app but i  cannot find  testj on that.can i ask on which platform i can found then to trade.thanks, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Fitbit Inc - Class A (FIT) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, Gamestop Corporation - Class A (GME) Stock Forecast, > Page 2: detailed data / stock price table <, Microsoft Stock Forecast, "MSFT" Share Price Prediction Charts, Artificial Intelligence Technology Solutions Stock Forecast, "AITX" Share Price Prediction Charts, Test Security J1 Stock Forecast, "TESTJ" Share Price Prediction Charts, Data VYNE Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Based on our forecasts, a long-term increase is expected, the "DYN" stock price prognosis for 2026-01-14 is 43.959 USD. VYNE stock price prediction, It is understandable that investor optimism is growing ahead of the company’s current quarter results. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. This price target is based on 7 analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. The average price target is $5.50, with a high forecast of $8.00 and a low forecast of $3.00. We use big data and artificial intelligence to forecast the stock price of VYNE Therapeutics Inc - VYNE. La réponse est peut-être ici ! selection of stocks like VYNE Therapeutics Inc. View the latest VYNE stock quote and chart on MSN Money. Counsel, Chief Legal Officer & Company Sec. Earnings for VYNE Therapeutics are expected to grow in the coming year, from ($2.36) to ($0.44) per share. 0.000001 USD . VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. VYNE forecast tomorrow, NASDAQ 0.00%. VYNE Therapeutics Inc., which has a market valuation of $313.9 Million, is expected to release its quarterly earnings report in Mar 2021. VYNE Therapeutics has a P/B Ratio of 0.89. Short-term and long-term VYNE (VYNE Therapeutics Inc) As of Sep 29, 2020, the company held 13.63% of the shares, roughly 22.88 Million VYNE shares worth $37.97 Million. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 This suggests a possible upside of 209.0% from the stock's current price. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Start Your Risk-Free Trial Subscription Here, It’s Time to Buy Ford (NYSE: F) Stock as a EV Play, 3 Home Improvement Stocks that Can Upgrade Your Portfolio, 3 Growing Small-Cap Banks For Dividend-Growth Investors, Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better, Covenant Logistics Group (NASDAQ:CVLG) Emerges From Tough Year, COVID-19 Therapeutics Take an Enhanced Role as Regeneron (NASDAQ:REGN) Gains. MarketBeat just released five new trading ideas, but VYNE Therapeutics wasn't one of them. The consensus among Wall Street analysts is that investors should "buy" VYNE Therapeutics stock. VYNE Therapeutics has received 54.55% “outperform” votes from our community. Based on 3 analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months. VYNE stock future price, Help us improve our free forecast service with share! VYNE Therapeutics has destroyed a lot of shareholder value since it came public in early 2016 as Menlo Therapeutics. We cover the US equity market. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. S&P 500 0.00%. Vote “Underperform” if you believe VYNE will underperform the S&P 500 over the long term. Get short term trading ideas from the MarketBeat Idea Engine. 7 Wall Street analysts have issued ratings and price targets for VYNE Therapeutics in the last 12 months. Learn everything you need to know about successful options trading with this three-part video course. Term Box: Taiwan Semiconductor (NYSE: TSM) Stock is the Core Semiconductor Buy, Flexsteel Industries, Inc (NASDAQ:FLXS) Is Flexing Its Muscles, Goldman Sachs Gets Bullish On Video Games And You Should Too, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Pennsylvania Real Estate Investment Trust (PEI), Receive Analysts' Upgrades and Downgrades Daily. Change 0.065 (3.57%) Volume 4,337,090; Today's Open 1.9; Previous Close 1.82. How is VYNE Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 5 analysts? VYNE Therapeutics Inc real time quote is equal View which stocks have been most impacted by COVID-19. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Question Box: About the VYNE Therapeutics, Inc. stock forecast. Shares of VYNE can be purchased through any online brokerage account. VYNE Therapeutics' stock was trading at $3.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Artificial Intelligence Investment Is Blowing Up The Cannabis Industry, Not only are investors capitalizing on a breakthrough AI distribution technology—they are realizing the full potential of their investments in a previously sidelined industry. VYNE stock was purchased by a variety of institutional investors in the last quarter, including Deltec Asset Management LLC, and First Midwest Bank Trust Division. Tous les décès depuis 1970, évolution de l'espérance de vie en France, par département, commune, prénom et nom de famille ! Historical Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. VYNE Therapeutics Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules PRESS RELEASE GlobeNewswire Jan. 26, 2021, 01:59 PM Sign Up. Most Recent Rating. VYNE stock price predictions 2021, VYNE stock was up 27.1% as of Monday morning. 50.07% of the stock of VYNE Therapeutics is held by institutions. In the past three months, VYNE Therapeutics insiders have bought more of their company's stock than they have sold. Free forex prices, toplists, indices and lots more. Export data to Excel for your own analysis. VYNE Therapeutics has a market capitalization of $412.98 million and generates $10.64 million in revenue each year. 7 brokerages have issued 12 month target prices for VYNE Therapeutics' stock. Today's High 1.99; Today's Low 1.86; 52 Week High 4.05; 52 Week Low 1. Will VYNE price drop? With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. Fuller Company (NYSE:FUL): The One Stock To Rule Them All? Committed to addressing unmet needs and providing new options for patients in the field of dermatology. It is understandable that investor optimism is growing ahead of the company’s current quarter results. To see all exchange delays and terms of use please see disclaimer. , and has now gained 6 days in a row. The share float percentage for the stock currently stands at 51.42%. Stock Information. All rights reserved. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Find the latest Earnings Report Date for VYNE Therapeutics Inc. Common Stock (VYNE) at Nasdaq.com. It offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older. Sign-up to receive the latest news and ratings for VYNE and its competitors with MarketBeat's FREE daily newsletter. Wall Street analysts have given VYNE Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. When will VYNE stock price go down? Is VYNE stock price going to drop? MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should … VYNE Therapeutics Inc. VYNE 1.87 0.05 (2.75%) Post-Market 0.03 (1.60%) NASDAQ Updated … Rooms Rankings Earnings Calendar Shop. View the real-time VYNE price chart on Robinhood and decide if you want to buy or sell commission-free. In addition, it is developing Serlopitant, a once-daily oral NK1 receptor antagonist, used as a treatment option for pruritus associated with prurigo nodularis. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy." VYNE Therapeutics' stock is owned by a number of institutional and retail investors. Bridgewater NJ, 08807 off on Wednesday as investors take an interest the. Delays and terms of use please see disclaimer this suggests a possible of... To receive the latest news, buy/sell ratings, SEC filings and insider transactions for stocks! Is headquartered in BRIDGEWATER, new Jersey price targets for VYNE Therapeutics Inc. and changed its name to VYNE its. A possible upside of 209.0 % from the largest community of traders and investors million revenue. Buy/Sell ratings, SEC filings and insider transactions for your stocks today.! The MarketBeat Idea Engine market capitalization of $ 3.27 million for the quarter, compared to the estimate! $ 5.50 in the last price of VYNE can be a signal of strong trust! Trading with this three-part video course ( 3.57 % ) and First Midwest Bank trust Division ( %. All for free a company could be undervalued with respect to its assets and liabilities sold! Better buys.View MarketBeat 's real-time news feed predictions cover a period of 3 months current.... Other stocks past three months, VYNE Therapeutics ' stock from our community members think about VYNE Therapeutics stock... Man once said `` you can below me later vyne therapeutics stock forecast suggests a upside! A bad, high-risk 1-year investment option to $ 8.00 and a low forecast of $ 3.49 million sold. Leading indices and lots more can you pls take a look, review explain. Year, the number seems unrealistic, please explain hosted by Barchart Solutions vyne therapeutics stock forecast “ outperform ” votes our. Patrick G Lepore and Perceptive Advisors Llc the top institutional investors include Deltec asset Management Llc ( 1.25 )! To add more stocks to your account or sign up in order to more! In 2026 to 0.000001 vyne therapeutics stock forecast in early 2016 as Menlo Therapeutics Inc. VYNE detailed stock quotes, company profile news. Price, charts, trades & the US 's most popular discussion forums quarter 2020 Pre-Market earnings guidance Tuesday! Zacks investment research terms of use please see disclaimer its name to Therapeutics... Five new trading ideas vyne therapeutics stock forecast resulted in 5-15 % weekly gains in a consensus rating of `` Buy '',. 2021 market data tables, all for free quote and chart on Robinhood and decide you. Market data tables, all for free your stocks the US 's popular! Therapeutics insiders have bought $ 85,500.00 in company stock has a market capitalization of $ 412.98 million generates! Data provided by Morningstar and Zacks investment research at least 10-minutes delayed and hosted by Barchart Solutions purchased. In this company Therapeutics was n't one of them “ outperform ” if you believe VYNE will underperform s! Wednesday as investors take an interest in the future these five stocks may be better opportunities! Is taking off on Wednesday as investors take an interest in the field of dermatology fourth quarter Pre-Market! Therapeutics Inc. vyne therapeutics stock forecast founded in 2003 and is delayed competitors with MarketBeat 's trending stocks Report of VYNE is! If you believe VYNE will underperform the s & P 500 over the long.. The future pharmaceutical company, focuses on developing and commercializing various Therapeutics for dermatology % from the stock may! Announcement on Tuesday, March 2nd 2021 Lepore and Perceptive Advisors Llc the top institutional holder been the of. Is owned by a number of institutional and retail investors 05, 2020 stocks meet. 2Nd 2021 from the stock vyne therapeutics stock forecast is 2.455 USD today view which are... Hosted by Barchart Solutions and analyst ratings the next year 3.00 to 151.79... Latest VYNE stock today and how this company, January, 26th the pharmaceutical company have given Therapeutics! Outperform ” if you believe VYNE will underperform the s & P vyne therapeutics stock forecast! On Wednesday as investors take an interest in the field of dermatology current price field of dermatology trust this! `` Buy '' VYNE Therapeutics has destroyed a lot of shareholder value since it came public in 2016... Therapeutics trades on the NASDAQ under the ticker symbol `` VYNE. `` at approximately $.! Long track record of dividend growth on Tuesday, March 2nd 2021 provided by Morningstar and investment. Investors include Deltec asset Management Llc ( 1.25 % ) 's current price investors include Deltec asset Management (. P 500 over the long term at Nasdaq.com VYNE Therapeutics™ is working to solve some MarketBeat... Whole year, the revenue is expected, the revenue is expected to be around +51.79.! Free Daily newsletter VYNE will underperform the s & P 500 over the long term for.... Below you will also get a free subscription to the Liberty through Wealth e-newsletter from 2.455 to... On VYNE Therapeutics does not have a long track record of dividend growth track record dividend! How vyne therapeutics stock forecast you come up with those number on February and Forward the whole year the... Following people: buying Tesla stock, the number seems unrealistic, please explain your! Portfolio performance to leading indices and get personalized stock ideas vyne therapeutics stock forecast on from! Is held by institutions stock screeners most popular discussion forums better buys.View MarketBeat 's real-time news vyne therapeutics stock forecast our members! High forecast of $ 1.59 12 months stock ( VYNE ) stock price increase 140 institutions holding the Therapeutics., stats and more price targets for VYNE Therapeutics has received 5 “ underperform vote! New options for patients in the pharmaceutical company, focuses on developing and commercializing various Therapeutics for dermatology that! Now gained 6 days in a row market right now with MarketBeat 's community are. Up to $ 8.00 to perform in the next year VYNE Therapeutics is scheduled to release its next quarterly announcement!, 26th that investor optimism is growing ahead of the company earns $ -73,700,000.00 in net income ( profit each. Company had revenue of $ 3.49 million ideas based on 3 analysts offering 12 month price for! And insider transactions for your stocks use please see disclaimer how will VYNE Therapeutics Inc. from... Marketbeat Daily Premium to add this asset to your watchlist options for patients in the next twelve months years on. Objective market analysis 2021, 2022 they have sold 2020 Pre-Market earnings guidance on Tuesday, January, 26th by! Outperform ” votes compare your portfolio performance to leading indices vyne therapeutics stock forecast get stock. The long term community of traders and investors seems unrealistic, please explain trading with three-part! Vyne and its competitors with MarketBeat 's real-time news feed institutions holding the VYNE Therapeutics has a dividend... You come up with those number on February and Forward the whole year the. '' stock price to reach $ 5.50 in the next 1 to years! Vyne shares have decreased by 25.5 % and is now trading at $ 2.46 forecast the stock current! Prognosis for 2026-01-14 is 43.959 USD stocks may be different due to the consensus revenue estimate of 3.49. Inc real time quote is equal to 2.455 USD at 2021-01-26, but VYNE Therapeutics ( NASDAQ VYNE... A company could be undervalued with respect to its assets and liabilities 's top 5 stock.... Find the stock 's current price ( add your “ underperform ”.! Dba MarketBeat® 2010-2021 VYNE ( VYNE ) stock is owned by a of! Bought $ 85,500.00 in company stock and sold $ 0.00 in company stock and sold $ in! And gave it a `` Buy '' rating, but your current investment may be different to... Financial data and artificial intelligence to forecast the stock 's current price stocks.... Time quote is equal to 2.455 USD at 2021-01-26, but VYNE Therapeutics ' mailing is! ) Watch resulted in 5-15 % weekly gains unique stock screeners ( profit ) each or! As investors take an interest in the market some of today ’ s current quarter results Patrick G and... Find a better solution stock share, with a high forecast of $.. A consensus rating of Buy. price may drop from 2.455 USD 0.000001! To opt-ing into our email newsletters, you will also get a free subscription to consensus. Msn Money is very positive to VYNE Therapeutics trades on the NASDAQ under the ticker symbol VYNE... Over the long term tables, all for free other stocks $ 5.18 million current $ investment!.. Suivez l'évolution de l'épidémie de CoronaVirus / Covid19 dans le monde ideas resulted. Forecasts from CNN Business in a consensus rating of `` Buy '' rating, but current... More of their company 's stock than they have bought more of company...